The FDA issued warning letters this week to two marketers of kratom products ''for illegally selling unapproved, misbranded kratom-containing products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms.'
Eric Webb, spokesperson for Cali Botanicals, says his company has changed the language on its product as the FDA requested."We were not attempting to deceive anybody," he says. He points out that ''All over [the site] it says this hasn't been evaluated by the FDA. It's more of a holistic treatment."Kratom is technically known asThe herb grows naturally in Thailand, Malaysia, Indonesia, and Papua New Guinea.
The herb is often used to treat pain and withdrawal from opioids. Kratom “has been shown numerous times in reports from users to help recovering Opiate addicts, treat pain, combat depression and anxiety, and much more,” says a petition from the American Kratom Association against making the herb a Schedule I drug. “There are many people who will suffer from this.”
Robert Glatter, MD, an emergency medicine doctor at Lenox Hill Hospital in New York, applauds the FDA for continuing to pressure manufacturers who market and distribute kratom in a misleading, harmful, or fraudulent manner.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA once again expands recall of blood pressure drugsThe recalled batches of the drug contain a chemical contaminant linked to cancer.
Read more »
Judge throws the book at a clinic offering unproven stem cell ‘treatments’In what may be the harshest enforcement order yet against a clinic pitching unproven and potentially harmful stem cell “treatments,” a federal judge has ordered a stem cell firm to cease offering the treatments. Columnist hiltzikm explains:
Read more »
New York's new LGBT-friendly elder housing is a lifeline, but only for a fewMore cities are investing in LGBT-friendly housing, but some people are slipping through the cracks.
Read more »
Medtronic recalls some insulin pumps as FDA warns they can be hackedMiniMed 508 Medtronic insulin pumps have cybersecurity problems that can't be updated or patched, and the company is recalling them as a result, the Food and Drug Administration said Thursday.
Read more »
Former FDA Commissioner Scott Gottlieb joins Pfizer's board of directorsScott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer's board of directors, the company announced Thursday.
Read more »
Medtronic recalls MiniMed insulin pumps as FDA warns about hacking riskThe US Food and Drug Administration issued a warning on Thursday about possible risk of hacking for some diabetes patients' insulin pumps. Certain insulin pumps from Medtronic MiniMed have been recalled due to potential cybersecurity risks.
Read more »